Dr. Reddy's Laboratories Files Routine 6-K
Ticker: RDY · Form: 6-K · Filed: Nov 7, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, compliance, foreign-private-issuer
TL;DR
DRL filed a 6-K, no major news, just compliance.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 7, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or operational updates but serves as a routine submission to the SEC.
Why It Matters
This filing indicates ongoing compliance with SEC reporting requirements for foreign private issuers, ensuring transparency for investors.
Risk Assessment
Risk Level: low — The filing is a routine procedural document and does not contain any new material information that would inherently increase risk.
Key Players & Entities
- DR REDDYS LABORATORIES LTD (company) — Filer
- 0001575872-24-001131 (filing_id) — Accession Number
- 20241107 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to submit information to the SEC.
Who is the filer of this document?
The filer is DR REDDYS LABORATORIES LTD.
What is the filing date of this report?
The filing date is November 7, 2024.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Yes, Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address of Dr. Reddy's Laboratories?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Filing Stats: 403 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-11-07 06:35:00
Filing Documents
- drr0692_6k.htm (6-K) — 13KB
- drr0692_ex99-1.htm (EX-99.1) — 8KB
- drr0692_ex99-1img01.jpg (GRAPHIC) — 4KB
- drr0692_ex99-1img02.jpg (GRAPHIC) — 4KB
- 0001575872-24-001131.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: November 6, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3